Speaker(s): 

Molly Rinkevich, PharmD, BCEMP, Geisinger Lewistown - has nothing to disclose.

Moderator(s): 

Michael M. O'Hara RPh, Centralized Clinical Pharmacy Services, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

  1. Review transmission, disease course, and complications of measles infection

  2. Review vaccine schedule for pediatric and adult patients

  3. Discuss indications and pharmacotherayp for post expose prophylaxis 

  4. Review Management strategies for active infection 

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Sarah F. Hale, PharmD, Daniel Longyhore, PharmD, Ed.D, BCACP, Michael M O’Hara RPh, and Mary Beth Mickel, CPhT have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None.

Session date: 
09/15/2026 - 4:00pm to 4:30pm EDT
Location: 
Virtual via Microsoft Teams
Danville, PA 17822
United States
  • 0.50 ACPE
  • 0.50 ACPE Tech
  • 0.50 Participation Credit
Please login or register to take this course.